{"id":"https://openalex.org/W2103266155","doi":"https://doi.org/10.1111/j.1464-5491.2006.01800.x","title":"Exenatide: effect of injection time on postprandial glucose in patients with Type 2 diabetes","display_name":"Exenatide: effect of injection time on postprandial glucose in patients with Type 2 diabetes","alternate_titles":[],"publication_year":2006,"publication_date":"2006-02-16","ids":{"openalex":"https://openalex.org/W2103266155","doi":"https://doi.org/10.1111/j.1464-5491.2006.01800.x","mag":"2103266155","pmid":"https://pubmed.ncbi.nlm.nih.gov/16492205"},"language":"en","primary_location":{"id":"doi:10.1111/j.1464-5491.2006.01800.x","doi":"https://doi.org/10.1111/j.1464-5491.2006.01800.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1464-5491.2006.01800.x","pdf_url":null,"source":{"id":"https://openalex.org/S72944096","display_name":"Diabetic Medicine","issn_l":"0742-3071","issn":["0742-3071","1096-9136","1464-5491"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetic Medicine","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2103266155"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5064098013","display_name":"Helle Linnebjerg","orcid":"https://orcid.org/0000-0001-5849-921X","observed_orcids":["https://orcid.org/0000-0001-5849-921X"]},"institutions":[{"id":"https://openalex.org/I4210095227","display_name":"Eli Lilly (United Kingdom)","ror":"https://ror.org/00psab413","country_code":"GB","type":"company","lineage":["https://openalex.org/I168537998","https://openalex.org/I4210095227"]}],"countries":["GB"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"H. Linnebjerg","raw_affiliation_strings":["Eli Lilly and Company Limited, Lilly Research Centre, Erl Wood Manor, UK. linnebjerg_helle@lilly.com","Eli Lilly and Company Limited, Lilly Research Centre, Erl Wood Manor, UK,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company Limited, Lilly Research Centre, Erl Wood Manor, UK. linnebjerg_helle@lilly.com","institution_ids":["https://openalex.org/I4210095227"]},{"raw_affiliation_string":"Eli Lilly and Company Limited, Lilly Research Centre, Erl Wood Manor, UK,","institution_ids":["https://openalex.org/I4210095227"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079794570","display_name":"Prajakti A. Kothare","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"P. A. Kothare","raw_affiliation_strings":["Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA and","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010436601","display_name":"Zachary Skrivanek","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Z. Skrivanek","raw_affiliation_strings":["Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA and","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022493856","display_name":"Amparo de la Pe\u00f1a","orcid":"https://orcid.org/0009-0009-6341-4933","observed_orcids":["https://orcid.org/0009-0009-6341-4933"]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"A. de la Pe\u00f1a","raw_affiliation_strings":["Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA and","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010487521","display_name":"Matthew E. Atkins","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210095227","display_name":"Eli Lilly (United Kingdom)","ror":"https://ror.org/00psab413","country_code":"GB","type":"company","lineage":["https://openalex.org/I168537998","https://openalex.org/I4210095227"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"M. Atkins","raw_affiliation_strings":["Eli Lilly and Company Limited, Lilly Research Centre, Erl Wood Manor, UK,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company Limited, Lilly Research Centre, Erl Wood Manor, UK,","institution_ids":["https://openalex.org/I4210095227"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111791896","display_name":"C. Steven Ernest","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"C. S. Ernest","raw_affiliation_strings":["Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA and","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5062021087","display_name":"MICHAEL E. TRAUTMANN","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"M. E. Trautmann","raw_affiliation_strings":["Lilly Forschung GmbH, Hamburg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lilly Forschung GmbH, Hamburg, Germany","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5064098013"],"corresponding_institution_ids":["https://openalex.org/I4210095227"],"apc_list":{"value":4870,"currency":"USD","value_usd":4870},"apc_paid":null,"fwci":3.6492,"has_fulltext":false,"cited_by_count":49,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.93181905,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":96},"biblio":{"volume":"23","issue":"3","first_page":"240","last_page":"245"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/exenatide","display_name":"exenatide","score":1.0},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9200000166893005},{"id":"https://openalex.org/keywords/injection-timing","display_name":"injection timing","score":0.6439999938011169},{"id":"https://openalex.org/keywords/postprandial-blood-glucose","display_name":"postprandial blood glucose","score":0.8539999723434448},{"id":"https://openalex.org/keywords/incretin-mimetics","display_name":"incretin mimetics","score":0.8309999704360962},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.8510000109672546},{"id":"https://openalex.org/keywords/flexible-dosing","display_name":"flexible dosing","score":0.7139999866485596},{"id":"https://openalex.org/keywords/hypoglycemia","display_name":"hypoglycemia","score":0.8320000171661377}],"concepts":[{"id":"https://openalex.org/C2780533449","wikidata":"https://www.wikidata.org/wiki/Q417762","display_name":"Exenatide","level":4,"score":0.9473347067832947},{"id":"https://openalex.org/C2778199505","wikidata":"https://www.wikidata.org/wiki/Q2992990","display_name":"Postprandial","level":3,"score":0.9066996574401855},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8898369073867798},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.7391128540039062},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.7149813175201416},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7030318379402161},{"id":"https://openalex.org/C87813604","wikidata":"https://www.wikidata.org/wiki/Q1242899","display_name":"Crossover study","level":4,"score":0.6467149257659912},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.5692524909973145},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.5634366273880005},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.4673096835613251},{"id":"https://openalex.org/C2780668416","wikidata":"https://www.wikidata.org/wiki/Q202758","display_name":"Hypoglycemia","level":3,"score":0.44168171286582947},{"id":"https://openalex.org/C2778345441","wikidata":"https://www.wikidata.org/wiki/Q6460735","display_name":"Meal","level":2,"score":0.4409253001213074},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.35855987668037415},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000077270","descriptor_name":"Exenatide","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D007279","descriptor_name":"Injections, Subcutaneous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007328","descriptor_name":"Insulin","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010455","descriptor_name":"Peptides","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D010455","descriptor_name":"Peptides","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D010455","descriptor_name":"Peptides","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D014688","descriptor_name":"Venoms","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D014688","descriptor_name":"Venoms","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D014688","descriptor_name":"Venoms","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D018592","descriptor_name":"Cross-Over Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019518","descriptor_name":"Postprandial Period","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019540","descriptor_name":"Area Under Curve","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1111/j.1464-5491.2006.01800.x","doi":"https://doi.org/10.1111/j.1464-5491.2006.01800.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1464-5491.2006.01800.x","pdf_url":null,"source":{"id":"https://openalex.org/S72944096","display_name":"Diabetic Medicine","issn_l":"0742-3071","issn":["0742-3071","1096-9136","1464-5491"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetic Medicine","raw_type":"journal-article"},{"id":"pmid:16492205","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16492205","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetic medicine : a journal of the British Diabetic Association","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9922999739646912,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320307758","display_name":"Eli Lilly and Company","ror":"https://ror.org/01qat3289"},{"id":"https://openalex.org/F4320307768","display_name":"Amylin Pharmaceuticals","ror":"https://ror.org/043cec594"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":20,"referenced_works":["https://openalex.org/W1910418518","https://openalex.org/W1971820070","https://openalex.org/W1984740259","https://openalex.org/W1985051436","https://openalex.org/W1986085856","https://openalex.org/W1993072922","https://openalex.org/W2027433835","https://openalex.org/W2068183831","https://openalex.org/W2096716906","https://openalex.org/W2101613382","https://openalex.org/W2108771199","https://openalex.org/W2115707749","https://openalex.org/W2140978079","https://openalex.org/W2142903571","https://openalex.org/W2143014102","https://openalex.org/W2161306825","https://openalex.org/W2162934281","https://openalex.org/W2167984392","https://openalex.org/W2337454357","https://openalex.org/W2344620176"],"related_works":["https://openalex.org/W2344620176","https://openalex.org/W2073375369","https://openalex.org/W2021513911","https://openalex.org/W2101613382","https://openalex.org/W3003490318","https://openalex.org/W2092171219","https://openalex.org/W2096235282","https://openalex.org/W1987319592","https://openalex.org/W1996154084","https://openalex.org/W2005582534"],"abstract_inverted_index":{"AIMS:":[0],"Exenatide":[1],"is":[2,17],"an":[3],"incretin":[4],"mimetic":[5],"whose":[6],"effect":[7,25],"on":[8,34,86],"glycaemic":[9],"control":[10],"in":[11,39,49,172,178,192,250],"patients":[12,40,47,180],"with":[13,41,127,138,157,219,256,260,273],"Type":[14,42],"2":[15,43],"diabetes":[16],"currently":[18],"under":[19,110],"investigation.":[20],"This":[21],"study":[22],"assessed":[23],"the":[24,111,139,193],"of":[26,37,62,70,238,263,268,281],"injection":[27],"time":[28,285],"relative":[29,80],"to":[30,81,118,227],"a":[31,82,212,290],"standardized":[32,83],"meal":[33,85,140,261],"postprandial":[35,107,112,144,251,269],"pharmacodynamics":[36],"exenatide":[38,71,104,130,160,228,246,264,282],"diabetes.":[44],"METHODS:":[45],"Eighteen":[46],"participated":[48],"this":[50,243],"single-centre,":[51],"open-label,":[52],"placebo-controlled,":[53],"randomized,":[54],"six-way":[55],"crossover":[56],"study.":[57],"Patients":[58],"received":[59],"subcutaneous":[60],"injections":[61],"either":[63],"placebo":[64,200],"(-15":[65],"min)":[66,136],"or":[67,77,137],"10":[68],"microg":[69],"at":[72,283],"-60,":[73],"-15,":[74],"0,":[75],"+30":[76],"+60":[78,166],"min":[79,288],"breakfast":[84],"six":[87],"consecutive":[88],"days.":[89],"Serial":[90],"blood":[91],"samples":[92],"were":[93,147,186,196,229,236],"assayed":[94],"for":[95,153,204],"plasma":[96,113,183,189,252],"glucose":[97,108,114,145,175,184,253,270],"and":[98,177,233,235,259],"insulin":[99,190,216],"concentrations.":[100],"RESULTS:":[101],"For":[102],"all":[103,154,205,245],"treatments,":[105],"incremental":[106],"area":[109],"curve":[115],"from":[116],"zero":[117],"6":[119],"h":[120],"(AUC0-6":[121],"h)":[122],"was":[123,131],"significantly":[124,148,197],"reduced":[125],"compared":[126,156,218,255,272],"placebo.":[128,158,220,257],"When":[129],"administered":[132],"before":[133,289],"(-60,":[134],"-15":[135],"(0":[141],"min),":[142],"peak":[143,174],"concentrations":[146,185,191],"decreased":[149],"(P":[150,201],"<":[151,164,202],"0.0001":[152],"treatments)":[155],"Post-meal":[159],"administration":[161,262],"(+30,":[162],"P":[163,168],"0.05;":[165],"min,":[167],"=":[169],"0.21)":[170],"resulted":[171],"smaller":[173],"reductions":[176,249],"some":[179],"transient":[181],"low":[182],"reported.":[187],"Peak":[188],"pre-meal":[194],"treatments":[195,247],"lower":[198],"than":[199],"0.05":[203],"treatments),":[206],"while":[207],"post-meal":[208,274],"dosing":[209,280],"groups":[210],"exhibited":[211],"trend":[213],"towards":[214],"higher":[215],"peaks":[217],"The":[221],"most":[222],"common":[223],"adverse":[224],"events":[225],"related":[226],"headache,":[230],"nausea,":[231],"dyspepsia":[232],"vomiting,":[234],"generally":[237],"mild-to-moderate":[239],"intensity.":[240],"CONCLUSIONS:":[241],"In":[242],"study,":[244],"demonstrated":[248],"excursions":[254,271],"Pre-meal":[258],"produced":[265],"greater":[266],"reduction":[267],"administration.":[275],"These":[276],"data":[277],"support":[278],"flexible":[279],"any":[284],"within":[286],"60":[287],"meal.":[291]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2103266155","counts_by_year":[{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-22T12:46:00.618207","created_date":"2016-06-24T00:00:00"}
